Crossmark

Development, verification, and comparison of a risk stratification model to identify potential population benefiting from chemotherapy in non-metastatic male breast cancer

Crossref DOI link: https://doi.org/10.1038/s41598-025-08440-1

Published Online: 2025-07-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Mingkun

Yao, Qing

Qin, Yuan

Hou, Niuniu

Tang, Xueyuan

Zhang, Juliang
License Information

Text and Data Mining valid from 2025-07-07

Version of Record valid from 2025-07-07
More Information

Article History

Received: 2 September 2024

Accepted: 20 June 2025

First Online: 7 July 2025

Declarations

:

: The authors declare no competing interests.

: This study was approved by the ethics committee of the local hospital (Xijing hospital), and because it was a retrospective study, permission for the exemption of informed consent was obtained.

Document is current

Any future updates will be listed below